Viability Test of α-Mangostin against Oral Squamous Cell Carcinoma

Author:

Rizqiawan Andra,Mulyawan Indra,Ta To Tran,Ashari Amalia Fauqiah,Soleh Adi Rizal,Busri Abdul Muin Hasan,Artha Dewati Ayusri,Shavia Cindy,El Fadhlallah Prasiddha Mahardhika

Abstract

Introduction: Oral Squamous Cell Carcinoma (OSCC) represents approximately 96% of the entire oral cancers. Epithelial-mesenchymal transition (EMT) is a factor contributing to the poor prognosis associated with OSCC. α-mangostin is one of the xanthones which show anti-cancer activities against some types of cancers and can suppress EMT-induced invasion by increasing E-cadherin expression. This study aimed to identify the viability of α-Mangostin to reduce the viable cells of HOC313. Methods: The role of α-mangostin to induce HOC313 cell culture at various concentrations which conducted on two groups: control group using only HOC313 cell line and intervention group comprising HOC313 cell line which added various concentrations. In this present study, cells were treated after reaching the confluency level of 80% in 5x103 cells/well. α-mangostin used had six concentrations: 1.25 µM, 2.5 µM, 3.75 µM, 5 µM, 6.25 µM, and 7.5 µM. Results: Concentration of α-mangostin had a significant effect on cell viability, p-value obtained was at 0.023 (p < 0.05). The Mann-Whitney test was also performed to identify significant differences in cell viability between control cells and all treatment cells were at 2.5 mg/ml and 5 mg/ml with the value p = 0.02 (p < 0.05). The concentrations α-mangostin at 1.25, 2.5, 3.75, 5, 6.25, and 7.5 µM is unable to reduce cell viability of HOC313. Conclusion: Low α-mangostin concentrations possibly result in a biphasic effect which leads to increase the viability cell of HOC313 cell line. Therefore, high α-mangostin concentrations might effectively inhibit cancer cell growth, migration, and invasion.

Publisher

Universiti Putra Malaysia

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3